Mid Atlantic Retina

04/28/2026

On Saturday, April 25th, Wills Eye Hospital, in partnership with Mid Atlantic Retina, held its 5th Wills Eye on Diabetes Day in Philadelphia. First held in 2022, this annual event has grown to include eighteen participating sites across Pennsylvania, Delaware, and New York, with a mission to raise awareness, eliminate diabetic vision loss and blindness.

Despite some rain, the event at Wills Eye Hospital had its highest participation rate to date. Over one hundred registrants had their vision evaluated, OCT, and wide-angle fundus photos taken. Snacks, childcare, relevant diabetic medical information, and counseling about obtaining medical coverage when needed were all provided to the participants for free.

04/24/2026

Diabetic eye disease is the #1 cause of blindness among working Americans. Allen Ho, MD spoke with CBS Philadelphia on the importance of diabetic eye screenings and the free diabetic eye screening event at Wills Eye Hospital this Saturday.

Wills Eye Hospital in Philadelphia and other sites around the region will host free eye screenings for Diabetes Day.

04/22/2026

David Xu, MD of Mid Atlantic Retina, Wills Eye Hospital was the first retina specialist in the northeastern US to administer Encelto. This newly approved surgical procedure implants an intraocular device to treat macular telangiectasia type 2 by continuously delivering ciliary neurotrophic factor to the retina.

Click here to learn more about the FDA approval: https://www.healio.com/news/ophthalmology/20250306/fda-approves-encelto-for-macular-telangiectasia-type-2

04/17/2026

Congratulations to Carl Regillo, MD, who has been recognized on The Ophthalmologist's 2026 Power List for driving progress in eye care through inclusion.
Click to view the full list: https://theophthalmologist.com/power-list/2026

Three Wills Eye Hospital physicians have been recognized for driving progress in eye care through inclusion on The Ophthalmologist's 2026 Power List

Please join us in congratulating Carl D. Regillo, MD, Retina Service Chief, Christopher J. Rapuano, MD, Cornea Service Chief and Peter and Ruth Laibson Cornea Service Chief Endowed Chair, and Sadeer B. Hannush, MD, Cornea Specialist.

Read our press release to learn about the key achievements of these talented individuals: https://www.willseye.org/press-release/wills-eye-physicians-recognized-on-the-ophthalmologist-2026-power-list/

View the full list: https://theophthalmologist.com/power-list/2026

04/13/2026

In this video, Sunir Garg, MD, discusses the impact of lifestyle changes on the development of geographic atrophy in people with high genetic risk. "Even if a person is genetically susceptible to developing AMD, you can reduce your risk of developing advanced AMD by about 55% to 60% by lifestyle modifications."

In this video from the Macula Society meeting, Sunir J. Garg, MD, FACS, FASRS, discusses the impact of lifestyle changes on the development of geographic atrophy in people with high genetic risk.“Even if a person is genetically susceptible to developing AMD, you can reduce your risk of develop...

03/03/2026

For the second year in a row, Mid Atlantic Retina has been recognized as the #1 ophthalmology practice with the most doctors on the 2026 Castle Connolly Top Doctors list. Congratulations to all our physicians for their dedication to our patients, research, and education for retinal disease. View the full list here - https://castleconnolly.com

03/03/2026

At the Hawaiian Eye 2026 meeting, Allen Ho, MD spoke about the recent progress and future development of gene therapy and what it could mean for patients with wet age-related macular degeneration.

WAIKOLOA, Hawaii — The recent progress and future development of gene therapy could help patients with wet age-related macular degeneration maintain vision, according to a speaker at Retina 2026. Allen C. Ho, MD, of Wills Eye Hospital, said gene therapy started in the subretinal space with gen...

02/25/2026

The Pennsylvania Academy of Ophthalmology has honored Drs. Allen Ho and Nellie Shields for their work starting and growing Wills Eye on Diabetes Day.

The annual event serves as a statewide initiative for diabetic eye screenings. Stay tuned for more information on this year's event, happening on April 25.

02/23/2026

Age-Related Macular Degeneration is the leading cause of blindness among older Americans. Call us to schedule your AMD exam - 1.800.331.6634

02/23/2026

Monday, February 23: Due to inclement weather, all Mid Atlantic Retina offices are closed. Patients with appointments will be contacted to reschedule.

02/19/2026

What’s the difference between Wet and Dry Age-Related Macular Degeneration? Sonia Mehta, MD and Ajay Kuriyan, MD answer your AMD questions.

02/18/2026

In this perspective for Healio, Dr. Jordan Deaner shares insights on the FDA's clearance of investigational new drug application to advance NOV05 in a phase 2 clinical trial in noninfectious anterior uveitis.

The FDA cleared an investigational new drug application to advance NOV05 in a phase 2 clinical trial in noninfectious anterior uveitis, according to a press release from Novaliq.The randomized, double-masked EYETAC clinical trial will evaluate NOV05 (tacrolimus ophthalmic solution in EyeSol) in pati...